[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oxycodone Market Growth 2024-2030

March 2024 | 110 pages | ID: GDBC16607EBEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Oxycodone market size was valued at US$ million in 2023. With growing demand in downstream market, the Oxycodone is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Oxycodone market. Oxycodone are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oxycodone. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oxycodone market.

Key Features:

The report on Oxycodone market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Oxycodone market. It may include historical data, market segmentation by Type (e.g., Long Acting Oxycodone, Short Acting Oxycodone), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oxycodone market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Oxycodone market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Oxycodone industry. This include advancements in Oxycodone technology, Oxycodone new entrants, Oxycodone new investment, and other innovations that are shaping the future of Oxycodone.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oxycodone market. It includes factors influencing customer ' purchasing decisions, preferences for Oxycodone product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oxycodone market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oxycodone market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oxycodone market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oxycodone industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oxycodone market.

Market Segmentation:

Oxycodone market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Long Acting Oxycodone
  • Short Acting Oxycodone
Segmentation by application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Johnson & Johnson
  • Sanofi
  • Pfizer
  • Purdue Pharma
  • Endo International
  • Teva Pharmaceuticals
  • Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • Mallinckrodt
  • Mylan
  • Sun Pharmaceutical (Chattem Chemicals)
  • Impax Laboratories
  • Indivior
Key Questions Addressed in this Report

What is the 10-year outlook for the global Oxycodone market?

What factors are driving Oxycodone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oxycodone market opportunities vary by end market size?

How does Oxycodone break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oxycodone Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Oxycodone by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Oxycodone by Country/Region, 2019, 2023 & 2030
2.2 Oxycodone Segment by Type
  2.2.1 Long Acting Oxycodone
  2.2.2 Short Acting Oxycodone
2.3 Oxycodone Sales by Type
  2.3.1 Global Oxycodone Sales Market Share by Type (2019-2024)
  2.3.2 Global Oxycodone Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Oxycodone Sale Price by Type (2019-2024)
2.4 Oxycodone Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Others
2.5 Oxycodone Sales by Application
  2.5.1 Global Oxycodone Sale Market Share by Application (2019-2024)
  2.5.2 Global Oxycodone Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Oxycodone Sale Price by Application (2019-2024)

3 GLOBAL OXYCODONE BY COMPANY

3.1 Global Oxycodone Breakdown Data by Company
  3.1.1 Global Oxycodone Annual Sales by Company (2019-2024)
  3.1.2 Global Oxycodone Sales Market Share by Company (2019-2024)
3.2 Global Oxycodone Annual Revenue by Company (2019-2024)
  3.2.1 Global Oxycodone Revenue by Company (2019-2024)
  3.2.2 Global Oxycodone Revenue Market Share by Company (2019-2024)
3.3 Global Oxycodone Sale Price by Company
3.4 Key Manufacturers Oxycodone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oxycodone Product Location Distribution
  3.4.2 Players Oxycodone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR OXYCODONE BY GEOGRAPHIC REGION

4.1 World Historic Oxycodone Market Size by Geographic Region (2019-2024)
  4.1.1 Global Oxycodone Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Oxycodone Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oxycodone Market Size by Country/Region (2019-2024)
  4.2.1 Global Oxycodone Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Oxycodone Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oxycodone Sales Growth
4.4 APAC Oxycodone Sales Growth
4.5 Europe Oxycodone Sales Growth
4.6 Middle East & Africa Oxycodone Sales Growth

5 AMERICAS

5.1 Americas Oxycodone Sales by Country
  5.1.1 Americas Oxycodone Sales by Country (2019-2024)
  5.1.2 Americas Oxycodone Revenue by Country (2019-2024)
5.2 Americas Oxycodone Sales by Type
5.3 Americas Oxycodone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oxycodone Sales by Region
  6.1.1 APAC Oxycodone Sales by Region (2019-2024)
  6.1.2 APAC Oxycodone Revenue by Region (2019-2024)
6.2 APAC Oxycodone Sales by Type
6.3 APAC Oxycodone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oxycodone by Country
  7.1.1 Europe Oxycodone Sales by Country (2019-2024)
  7.1.2 Europe Oxycodone Revenue by Country (2019-2024)
7.2 Europe Oxycodone Sales by Type
7.3 Europe Oxycodone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oxycodone by Country
  8.1.1 Middle East & Africa Oxycodone Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Oxycodone Revenue by Country (2019-2024)
8.2 Middle East & Africa Oxycodone Sales by Type
8.3 Middle East & Africa Oxycodone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxycodone
10.3 Manufacturing Process Analysis of Oxycodone
10.4 Industry Chain Structure of Oxycodone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oxycodone Distributors
11.3 Oxycodone Customer

12 WORLD FORECAST REVIEW FOR OXYCODONE BY GEOGRAPHIC REGION

12.1 Global Oxycodone Market Size Forecast by Region
  12.1.1 Global Oxycodone Forecast by Region (2025-2030)
  12.1.2 Global Oxycodone Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxycodone Forecast by Type
12.7 Global Oxycodone Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Oxycodone Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Sanofi
  13.2.1 Sanofi Company Information
  13.2.2 Sanofi Oxycodone Product Portfolios and Specifications
  13.2.3 Sanofi Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Sanofi Main Business Overview
  13.2.5 Sanofi Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Oxycodone Product Portfolios and Specifications
  13.3.3 Pfizer Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Purdue Pharma
  13.4.1 Purdue Pharma Company Information
  13.4.2 Purdue Pharma Oxycodone Product Portfolios and Specifications
  13.4.3 Purdue Pharma Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Purdue Pharma Main Business Overview
  13.4.5 Purdue Pharma Latest Developments
13.5 Endo International
  13.5.1 Endo International Company Information
  13.5.2 Endo International Oxycodone Product Portfolios and Specifications
  13.5.3 Endo International Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Endo International Main Business Overview
  13.5.5 Endo International Latest Developments
13.6 Teva Pharmaceuticals
  13.6.1 Teva Pharmaceuticals Company Information
  13.6.2 Teva Pharmaceuticals Oxycodone Product Portfolios and Specifications
  13.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Teva Pharmaceuticals Main Business Overview
  13.6.5 Teva Pharmaceuticals Latest Developments
13.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  13.7.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
  13.7.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolios and Specifications
  13.7.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Main Business Overview
  13.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Latest Developments
13.8 Mallinckrodt
  13.8.1 Mallinckrodt Company Information
  13.8.2 Mallinckrodt Oxycodone Product Portfolios and Specifications
  13.8.3 Mallinckrodt Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Mallinckrodt Main Business Overview
  13.8.5 Mallinckrodt Latest Developments
13.9 Mylan
  13.9.1 Mylan Company Information
  13.9.2 Mylan Oxycodone Product Portfolios and Specifications
  13.9.3 Mylan Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Mylan Main Business Overview
  13.9.5 Mylan Latest Developments
13.10 Sun Pharmaceutical (Chattem Chemicals)
  13.10.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
  13.10.2 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolios and Specifications
  13.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Sun Pharmaceutical (Chattem Chemicals) Main Business Overview
  13.10.5 Sun Pharmaceutical (Chattem Chemicals) Latest Developments
13.11 Impax Laboratories
  13.11.1 Impax Laboratories Company Information
  13.11.2 Impax Laboratories Oxycodone Product Portfolios and Specifications
  13.11.3 Impax Laboratories Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Impax Laboratories Main Business Overview
  13.11.5 Impax Laboratories Latest Developments
13.12 Indivior
  13.12.1 Indivior Company Information
  13.12.2 Indivior Oxycodone Product Portfolios and Specifications
  13.12.3 Indivior Oxycodone Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Indivior Main Business Overview
  13.12.5 Indivior Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Oxycodone Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oxycodone Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Long Acting Oxycodone
Table 4. Major Players of Short Acting Oxycodone
Table 5. Global Oxycodone Sales by Type (2019-2024) & (K Pcs)
Table 6. Global Oxycodone Sales Market Share by Type (2019-2024)
Table 7. Global Oxycodone Revenue by Type (2019-2024) & ($ million)
Table 8. Global Oxycodone Revenue Market Share by Type (2019-2024)
Table 9. Global Oxycodone Sale Price by Type (2019-2024) & (USD/Pcs)
Table 10. Global Oxycodone Sales by Application (2019-2024) & (K Pcs)
Table 11. Global Oxycodone Sales Market Share by Application (2019-2024)
Table 12. Global Oxycodone Revenue by Application (2019-2024)
Table 13. Global Oxycodone Revenue Market Share by Application (2019-2024)
Table 14. Global Oxycodone Sale Price by Application (2019-2024) & (USD/Pcs)
Table 15. Global Oxycodone Sales by Company (2019-2024) & (K Pcs)
Table 16. Global Oxycodone Sales Market Share by Company (2019-2024)
Table 17. Global Oxycodone Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Oxycodone Revenue Market Share by Company (2019-2024)
Table 19. Global Oxycodone Sale Price by Company (2019-2024) & (USD/Pcs)
Table 20. Key Manufacturers Oxycodone Producing Area Distribution and Sales Area
Table 21. Players Oxycodone Products Offered
Table 22. Oxycodone Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oxycodone Sales by Geographic Region (2019-2024) & (K Pcs)
Table 26. Global Oxycodone Sales Market Share Geographic Region (2019-2024)
Table 27. Global Oxycodone Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Oxycodone Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Oxycodone Sales by Country/Region (2019-2024) & (K Pcs)
Table 30. Global Oxycodone Sales Market Share by Country/Region (2019-2024)
Table 31. Global Oxycodone Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Oxycodone Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Oxycodone Sales by Country (2019-2024) & (K Pcs)
Table 34. Americas Oxycodone Sales Market Share by Country (2019-2024)
Table 35. Americas Oxycodone Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Oxycodone Revenue Market Share by Country (2019-2024)
Table 37. Americas Oxycodone Sales by Type (2019-2024) & (K Pcs)
Table 38. Americas Oxycodone Sales by Application (2019-2024) & (K Pcs)
Table 39. APAC Oxycodone Sales by Region (2019-2024) & (K Pcs)
Table 40. APAC Oxycodone Sales Market Share by Region (2019-2024)
Table 41. APAC Oxycodone Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Oxycodone Revenue Market Share by Region (2019-2024)
Table 43. APAC Oxycodone Sales by Type (2019-2024) & (K Pcs)
Table 44. APAC Oxycodone Sales by Application (2019-2024) & (K Pcs)
Table 45. Europe Oxycodone Sales by Country (2019-2024) & (K Pcs)
Table 46. Europe Oxycodone Sales Market Share by Country (2019-2024)
Table 47. Europe Oxycodone Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Oxycodone Revenue Market Share by Country (2019-2024)
Table 49. Europe Oxycodone Sales by Type (2019-2024) & (K Pcs)
Table 50. Europe Oxycodone Sales by Application (2019-2024) & (K Pcs)
Table 51. Middle East & Africa Oxycodone Sales by Country (2019-2024) & (K Pcs)
Table 52. Middle East & Africa Oxycodone Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Oxycodone Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Oxycodone Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Oxycodone Sales by Type (2019-2024) & (K Pcs)
Table 56. Middle East & Africa Oxycodone Sales by Application (2019-2024) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Oxycodone
Table 58. Key Market Challenges & Risks of Oxycodone
Table 59. Key Industry Trends of Oxycodone
Table 60. Oxycodone Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oxycodone Distributors List
Table 63. Oxycodone Customer List
Table 64. Global Oxycodone Sales Forecast by Region (2025-2030) & (K Pcs)
Table 65. Global Oxycodone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Oxycodone Sales Forecast by Country (2025-2030) & (K Pcs)
Table 67. Americas Oxycodone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Oxycodone Sales Forecast by Region (2025-2030) & (K Pcs)
Table 69. APAC Oxycodone Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Oxycodone Sales Forecast by Country (2025-2030) & (K Pcs)
Table 71. Europe Oxycodone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Oxycodone Sales Forecast by Country (2025-2030) & (K Pcs)
Table 73. Middle East & Africa Oxycodone Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Oxycodone Sales Forecast by Type (2025-2030) & (K Pcs)
Table 75. Global Oxycodone Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Oxycodone Sales Forecast by Application (2025-2030) & (K Pcs)
Table 77. Global Oxycodone Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Johnson & Johnson Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Oxycodone Product Portfolios and Specifications
Table 80. Johnson & Johnson Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. Sanofi Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Oxycodone Product Portfolios and Specifications
Table 85. Sanofi Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Pfizer Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Oxycodone Product Portfolios and Specifications
Table 90. Pfizer Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Purdue Pharma Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 94. Purdue Pharma Oxycodone Product Portfolios and Specifications
Table 95. Purdue Pharma Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 96. Purdue Pharma Main Business
Table 97. Purdue Pharma Latest Developments
Table 98. Endo International Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 99. Endo International Oxycodone Product Portfolios and Specifications
Table 100. Endo International Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 101. Endo International Main Business
Table 102. Endo International Latest Developments
Table 103. Teva Pharmaceuticals Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pharmaceuticals Oxycodone Product Portfolios and Specifications
Table 105. Teva Pharmaceuticals Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 106. Teva Pharmaceuticals Main Business
Table 107. Teva Pharmaceuticals Latest Developments
Table 108. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 109. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolios and Specifications
Table 110. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 111. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Main Business
Table 112. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Latest Developments
Table 113. Mallinckrodt Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 114. Mallinckrodt Oxycodone Product Portfolios and Specifications
Table 115. Mallinckrodt Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 116. Mallinckrodt Main Business
Table 117. Mallinckrodt Latest Developments
Table 118. Mylan Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 119. Mylan Oxycodone Product Portfolios and Specifications
Table 120. Mylan Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 121. Mylan Main Business
Table 122. Mylan Latest Developments
Table 123. Sun Pharmaceutical (Chattem Chemicals) Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 124. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolios and Specifications
Table 125. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 126. Sun Pharmaceutical (Chattem Chemicals) Main Business
Table 127. Sun Pharmaceutical (Chattem Chemicals) Latest Developments
Table 128. Impax Laboratories Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 129. Impax Laboratories Oxycodone Product Portfolios and Specifications
Table 130. Impax Laboratories Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 131. Impax Laboratories Main Business
Table 132. Impax Laboratories Latest Developments
Table 133. Indivior Basic Information, Oxycodone Manufacturing Base, Sales Area and Its Competitors
Table 134. Indivior Oxycodone Product Portfolios and Specifications
Table 135. Indivior Oxycodone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 136. Indivior Main Business
Table 137. Indivior Latest Developments

LIST OF FIGURES

Figure 1. Picture of Oxycodone
Figure 2. Oxycodone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxycodone Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Oxycodone Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oxycodone Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Long Acting Oxycodone
Figure 10. Product Picture of Short Acting Oxycodone
Figure 11. Global Oxycodone Sales Market Share by Type in 2023
Figure 12. Global Oxycodone Revenue Market Share by Type (2019-2024)
Figure 13. Oxycodone Consumed in Hospital Pharmacies
Figure 14. Global Oxycodone Market: Hospital Pharmacies (2019-2024) & (K Pcs)
Figure 15. Oxycodone Consumed in Retail Pharmacies
Figure 16. Global Oxycodone Market: Retail Pharmacies (2019-2024) & (K Pcs)
Figure 17. Oxycodone Consumed in Others
Figure 18. Global Oxycodone Market: Others (2019-2024) & (K Pcs)
Figure 19. Global Oxycodone Sales Market Share by Application (2023)
Figure 20. Global Oxycodone Revenue Market Share by Application in 2023
Figure 21. Oxycodone Sales Market by Company in 2023 (K Pcs)
Figure 22. Global Oxycodone Sales Market Share by Company in 2023
Figure 23. Oxycodone Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Oxycodone Revenue Market Share by Company in 2023
Figure 25. Global Oxycodone Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oxycodone Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oxycodone Sales 2019-2024 (K Pcs)
Figure 28. Americas Oxycodone Revenue 2019-2024 ($ Millions)
Figure 29. APAC Oxycodone Sales 2019-2024 (K Pcs)
Figure 30. APAC Oxycodone Revenue 2019-2024 ($ Millions)
Figure 31. Europe Oxycodone Sales 2019-2024 (K Pcs)
Figure 32. Europe Oxycodone Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Oxycodone Sales 2019-2024 (K Pcs)
Figure 34. Middle East & Africa Oxycodone Revenue 2019-2024 ($ Millions)
Figure 35. Americas Oxycodone Sales Market Share by Country in 2023
Figure 36. Americas Oxycodone Revenue Market Share by Country in 2023
Figure 37. Americas Oxycodone Sales Market Share by Type (2019-2024)
Figure 38. Americas Oxycodone Sales Market Share by Application (2019-2024)
Figure 39. United States Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Oxycodone Sales Market Share by Region in 2023
Figure 44. APAC Oxycodone Revenue Market Share by Regions in 2023
Figure 45. APAC Oxycodone Sales Market Share by Type (2019-2024)
Figure 46. APAC Oxycodone Sales Market Share by Application (2019-2024)
Figure 47. China Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Oxycodone Sales Market Share by Country in 2023
Figure 55. Europe Oxycodone Revenue Market Share by Country in 2023
Figure 56. Europe Oxycodone Sales Market Share by Type (2019-2024)
Figure 57. Europe Oxycodone Sales Market Share by Application (2019-2024)
Figure 58. Germany Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Oxycodone Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Oxycodone Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Oxycodone Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Oxycodone Sales Market Share by Application (2019-2024)
Figure 67. Egypt Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Oxycodone Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Oxycodone in 2023
Figure 73. Manufacturing Process Analysis of Oxycodone
Figure 74. Industry Chain Structure of Oxycodone
Figure 75. Channels of Distribution
Figure 76. Global Oxycodone Sales Market Forecast by Region (2025-2030)
Figure 77. Global Oxycodone Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Oxycodone Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Oxycodone Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Oxycodone Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Oxycodone Revenue Market Share Forecast by Application (2025-2030)


More Publications